Retention of Functional DC-NK Cross-Talk Following up to 18 Weeks Therapy Interruptions in Chronically Suppressed HIV Type 1(+) Subjects

Documenti analoghi

• Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection
  di: Papasavvas, Emmanouil, et al.
  Pubblicazione: (2004)
• Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients
  di: Papasavvas, Emmanouil, et al.
  Pubblicazione: (2009)
• Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapy
  di: Papasavvas, Emmanouil, et al.
  Pubblicazione: (2008)
• Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV
  di: PAPASAVVAS, Emmanouil, et al.
  Pubblicazione: (2018)
• Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patients
  di: Papasavvas, Emmanouil, et al.
  Pubblicazione: (2015)